Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear

May 5, 2015 updated by: Johnson & Johnson Vision Care, Inc.

Evaluation of Fit and Visual Acuity of the Investigational Toric Lens in Two Phases: Part B: A Dispensing Cross-over Comparison to SofLens66 Toric

The purpose of this study is to determine the relative performance of a new toric soft contact lens against a toric contact lens currently available in market, specifically with regards to the comfort and vision after two weeks of use.

Study Overview

Status

Completed

Conditions

Detailed Description

Dispensing, single-masked (subject-masked), randomized, 2-visit controlled study of two-weeks duration.

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: Prior to being considered eligible to participate in this study, subjects MUST

  1. be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).
  2. be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy.
  3. have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
  4. be able and willing to adhere to the instructions set forth in the protocol.
  5. agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
  6. have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
  7. have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
  8. be in good general health, based on his/her knowledge.
  9. read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.

Exclusion Criteria:

  1. The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.
  2. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
  3. The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).
  4. Slit lamp findings that would contraindicate contact lens wear such as:

    • Pathological dry eye or associated findings
    • Pterygium or corneal scars within the visual axis
    • Neovascularization >1mm in from the limbus
    • History of giant papillary conjunctivitis (GPC) worse than Grade 2
    • Anterior uveitis or iritis (past or present)
    • Seborrhoeic eczema, seborrhoeic conjunctivitis
  5. A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
  6. A known history of corneal hypoesthesia (reduced corneal sensitivity.)
  7. Aphakia, keratoconus or a highly irregular cornea.
  8. Current pregnancy or lactation (to the best of the subject's knowledge).
  9. Active participation in another clinical study at any time during this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: senofilcon A toric / alphafilcon A toric
senofilcon A toric contact lenses worn daily during the first period, then alphafilcon A toric contact lenses worn daily during the second period
contact lens
Other Names:
  • SofLens66 Toric
contact lens
Other: alphafilcon A toric / senofilcon A toric
alphafilcon A toric contact lenses worn daily during the first period, then senofilcon A toric contact lenses worn daily during the second period
contact lens
Other Names:
  • SofLens66 Toric
contact lens

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective Reported Vision
Time Frame: 1 week
A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score >0 then greater vision, if <0 then lesser vision.
1 week
Subject Reported Lens Comfort.
Time Frame: 1 week
A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is >0 indicates comfortable and <0 indicates uncomfortable.
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jason Chin, O.D.
  • Principal Investigator: James Fujimoto, O.D.
  • Principal Investigator: Dennis Kuwuabara, O.D., Eye Care Associates of Hawaii
  • Principal Investigator: Mark Nakano, O.D., Mark E. Nakano Optometric Corp.
  • Principal Investigator: Kevin Rosin, O.D., Drs. Farkas, Kassalow, Resnick & Associates
  • Principal Investigator: Jennifer Kao, O.D.
  • Principal Investigator: Weslie Hamada, O.D., Arthur T. Kobayashi, O.D., Inc.
  • Principal Investigator: Ikuko Sugimoto, O.D., unaffilliated

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2007

Primary Completion (Actual)

December 1, 2007

Study Completion (Actual)

December 1, 2007

Study Registration Dates

First Submitted

December 20, 2007

First Submitted That Met QC Criteria

December 31, 2007

First Posted (Estimate)

January 2, 2008

Study Record Updates

Last Update Posted (Estimate)

May 21, 2015

Last Update Submitted That Met QC Criteria

May 5, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CR-0714B

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Astigmatism

Clinical Trials on alphafilcon A toric

3
Subscribe